Skip to main content

Table 4 Total hemoglobin concentration of US-DOT according to pathologic biomarkers

From: US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers

  Total hemoglobin concentration (μmol/L)
   Mean p
Tumor size <2 cm (n = 20) 172.15 0.440
≥2 cm (n = 17) 192.06  
HG Low (n = 16) 147.98 0.019
High (n = 21) 206.68  
ER Neg (n = 15) 212.27 0.041
Pos (n = 22) 160.02  
PR Neg (n = 13) 211.86 0.075
Pos (n = 24) 164.73  
HER-2 Neg (n = 31) 179.63 0.769
Pos (n = 6) 189.91  
TNBC Neg (n = 27) 173.12 0.294
Pos (n = 10) 203.38  
Ki-67 Low (n = 18) 153.52 0.030
High (n = 19) 207.61  
LVI Neg (n = 23) 175.45 0.581
Pos (n = 3) 146.14  
LN mets Neg (n = 24) 179.84 0.879
Pos (n = 13) 183.97  
mets Neg (n = 36) 180.36 0.663
Pos (n = 1) 214.97